Therefore, the synergistic upregulation of the LPL/FABP4/CPT1 molecules in the NASH stage may accelerate the occurrence of liver cancer by nourishing the TICs formation. Here, CPT1A is linked to metabolic dysfunction-associated steatohepatitis.